mafia

Big Pharma corporations have a common goal of producing a variety of pharmacologics to manage diseases indefinitely. Their primary objective is to make money. Their financial blueprint is predicated on extortion practices.

Extortion, by definition, is the act of forcing people to pay money by threatening them in some way. In the case of big pharma, the extortion schemes are directly tied to presenting healthcare consumers with a constant risk of contracting illnesses or diseases.

Pharma companies strongly encourage healthcare consumers to spend X amount of dollars buying drug products annually to “protect” their health and well-being from various diseases. The catch is that the big pharma industry corporations are the entities that create the diseases (intellectual properties) that pose regular risks to all healthcare consumers.

In the US, the CDC is the regulatory body used to coerce unsuspecting healthcare consumers into following the big pharma scheme!

Big pharma extorsion practices described above mirror the well-known and publicized criminal operations of famous crime families that operate realm-wide and are referred to as the mafia.

Where do you think the…

…cancers come from?

…autoimmune disorders come from?

…childhood diseases come from?

…iatrogenic diseases come from?

…novel viruses come from?

…genetic diseases come from?

Vaccines are the cure for health!

Don’t get “stuck” believing the lies!

____________________

Dr. John Reizer is an American author, filmmaker, and retired chiropractor.

John has written several novellas and is the founder and chief editor of the popular alternative news blog, NoFakeNews.net.

Dr. Reizer is a former associate professor of clinical sciences at Sherman College of Chiropractic in Spartanburg, South Carolina.

His most recent works, Answers, The Blue Marble, Plandemic, The Visitors, Aftermath, False Memory, The Homecoming, Frequency, and The Target List, are science fiction thrillers.

John’s novel, The Target List, was released as a feature film under the title Target List in April 2023.

_____________________